Menu
GeneBe

1-154568046-T-A

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2

The NM_000748.3(CHRNB2):c.2T>A(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CHRNB2
NM_000748.3 start_lost

Scores

6
5
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.20
Variant links:
Genes affected
CHRNB2 (HGNC:1962): (cholinergic receptor nicotinic beta 2 subunit) Neuronal acetylcholine receptors are homo- or heteropentameric complexes composed of homologous alpha and beta subunits. They belong to a superfamily of ligand-gated ion channels which allow the flow of sodium and potassium across the plasma membrane in response to ligands such as acetylcholine and nicotine. This gene encodes one of several beta subunits. Mutations in this gene are associated with autosomal dominant nocturnal frontal lobe epilepsy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CHRNB2NM_000748.3 linkuse as main transcriptc.2T>A p.Met1? start_lost 1/6 ENST00000368476.4
CHRNB2XR_001736952.3 linkuse as main transcriptn.269T>A non_coding_transcript_exon_variant 1/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CHRNB2ENST00000368476.4 linkuse as main transcriptc.2T>A p.Met1? start_lost 1/61 NM_000748.3 P4
CHRNB2ENST00000637900.1 linkuse as main transcriptc.2T>A p.Met1? start_lost 1/65 A1
CHRNB2ENST00000636034.1 linkuse as main transcriptc.2T>A p.Met1? start_lost, NMD_transcript_variant 1/95

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1441432
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
715796
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Autosomal dominant nocturnal frontal lobe epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeNov 08, 2022Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1475973). This variant has not been reported in the literature in individuals affected with CHRNB2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the CHRNB2 mRNA. The next in-frame methionine is located at codon 61. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.16
Cadd
Uncertain
24
Dann
Benign
0.97
DEOGEN2
Benign
0.27
T;.
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Benign
0.36
N
LIST_S2
Uncertain
0.90
D;D
M_CAP
Pathogenic
0.74
D
MetaRNN
Pathogenic
0.98
D;D
MetaSVM
Uncertain
-0.22
T
MutationTaster
Benign
1.0
D
PROVEAN
Benign
-1.0
N;.
REVEL
Uncertain
0.57
Sift
Pathogenic
0.0
D;.
Sift4G
Pathogenic
0.0
D;.
Polyphen
0.72
P;.
Vest4
0.93
MutPred
0.99
Gain of catalytic residue at M1 (P = 0.0117);Gain of catalytic residue at M1 (P = 0.0117);
MVP
0.95
ClinPred
0.84
D
GERP RS
4.4
Varity_R
0.91
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-154540522; API